To address limitations in diabetes subtype diagnoses recorded in registers, we aimed to systematically classify 18,985 individuals from the All New Diabetics in Scania (ANDIS) cohort and compare them with Swedish National Diabetes Register (NDR) diagnoses. Type 1 and type 2 diabetes polygenic risk scores (PRS1 and PRS2, respectively) were used for genetic validation. We […]
Read MoreMonth: November 2026
Mitochondrial Dysfunction Across Renal Compartments in Diabetic Kidney Disease
Diabetic kidney disease (DKD) remains a leading cause of chronic kidney disease and kidney failure despite considerable therapeutic progress. Mitochondrial dysfunction has emerged as a central mechanism linking diabetic metabolic stress to progressive renal injury, yet it is often described as a generalized, whole-kidney abnormality. This view is incomplete because renal compartments differ in metabolic […]
Read MoreSkeletal Muscle DPT Ameliorates Obesity and Metabolic Dysfunction via the PERK/eIF2α/ATF4-GDF15 Axis
Skeletal muscle plays a pivotal role in maintaining metabolic homeostasis by acting as a primary site for glucose disposal and insulin-mediated energy use. Here, through RNA sequencing of skeletal muscle from individuals with normal weight versus obesity, we identified that the extracellular matrix–related gene dermatopontin (DPT) was significantly upregulated in the individuals with obesity. By […]
Read MoreReversal of T1D and Rapid Reduction of β-Cell Stress by IL-10–Dependent MDSCs Induced by TLR4-Ab
Type 1 diabetes (T1D) is caused by the autoimmune destruction of insulin-producing pancreatic β-cells. We published that an IgG3 Toll-like receptor 4 (TLR4)/myeloid differentiation factor 2 (MD2) agonistic antibody (TLR4-Ab) reversed acute T1D in NOD mice by induction of myeloid-derived suppressor cells (MDSCs), but the mechanism of MDSC induction was unclear. Here we show that […]
Read MoreAn Incretin-Dependent Modulation of Periprandial Neutrophilia
Daily cycles of fasting and feeding shape systemic metabolism, yet how innate immunity senses these transitions remains unclear. Chronic high-fat diet (HFD) primes granulocyte-monocyte progenitors to generate clones with heightened inflammasome activity and excessive production of interleukin-6 (IL-6) and IL-1β. Whether periprandial states influence immune surveillance remains unknown. We profiled periprandial immune adaptations in mice […]
Read MoreAmino Acid Profiles Distinguish Glycemic Phenotypes in Childhood and Predict 10-Year Risk of Dysglycemia in Young Adults: The BCAMS Study
Amino acid (AA) dysregulation has been associated with metabolic diseases. However, its potential as a childhood determinant of adult diabetes risk remains understudied, particularly among children with normoglycemia. Leveraging a 10-year follow-up cohort, we investigated whether AA profiles distinguished childhood glycemic phenotypes and predicted future diabetes risk. Among 947 children from the Beijing Children and […]
Read MoreAccelerated Epigenetic Ageing in Diabetic Kidney Disease: A Comparison of 10 Epigenetic Clock Measures in Individuals With Type 1 Diabetes
To characterize accelerated epigenetic ageing in individuals with diabetic kidney disease (DKD) and type 1 diabetes, 10 epigenetic clocks were generated for those with type 1 diabetes, with (case patients) or without (control participants) DKD, within the All Ireland–Warren 3–Genetics of Kidneys in Diabetes UK and Belfast Renal Transplant (UK-RoI; n = 464) and Finnish […]
Read MoreClinical Trial Design Considerations for the Development of Disease-Modifying Therapies for Type 1 Diabetes
Type 1 diabetes remains a compelling target for disease-modifying therapy (DMT) development. The autoimmune pathophysiology is well characterized, a staging framework is established, and regulatory precedent now exists following the approval of teplizumab. While β-cell preservation has been demonstrated for several DMTs in phase 2 trials, few have advanced to registrational studies. This article is […]
Read MoreDisrupting the PNPLA3-ABHD5 Interaction Stimulates Lipolysis and Improves PNPLA3-I148M–Associated Hepatic Steatosis
People with an I148M mutation in the PNPLA3 protein are at high risk of developing hepatic steatosis and progressive liver disease. The PNPLA3-I148M mutant protein accumulates on the membrane of lipid droplets (LDs) where it can interfere with the function of adipose tissue triglyceride lipase (ATGL) by depleting their shared cofactor α/β-hydrolase domain-containing protein 5 […]
Read MoreProtective Effects of PD-L1–Overexpressing MSCs and Their Derived Extracellular Vesicles in Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disorder characterized by T cell-mediated destruction of pancreatic β-cells that leads to lifelong dependence on insulin therapy. This study explores the therapeutic potential and mechanistic insights of human mesenchymal stromal/stem cells (MSCs) engineered to overexpress programmed death ligand-1 (PD-L1) (PD-L1-MSCs), as well as their extracellular vesicles (PEVs), in […]
Read More